Palemo Holdings
2778
Spancrete
5277
Renascience
4889
Oncolys BioPharma
4588
Kitagawa Seiki
6327
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 280.09%304.56M | 54.76%-169.11M | 28.98%-373.77M | -349.34%-526.27M | -62.72%211.06M | 21.23%566.14M | -6.96%466.99M | -18.21%501.93M | -16.84%613.69M | 6.70%737.93M |
Net profit before non-cash adjustment | 166.07%98.62M | 77.73%-149.27M | 26.65%-670.22M | -43.75%-913.79M | -1,560.50%-635.67M | -42.26%43.52M | 147.42%75.38M | -282.95%-158.96M | -60.57%86.89M | 72.89%220.37M |
Total adjustment of non-cash items | 389.93%232M | -84.68%47.35M | -30.07%309.03M | -43.11%441.88M | 54.74%776.73M | 8.48%501.96M | -30.60%462.7M | 25.05%666.74M | 1.16%533.16M | -14.40%527.03M |
-Depreciation and amortization | 47.76%178.04M | -37.83%120.5M | -17.09%193.83M | -21.37%233.79M | -11.30%297.34M | -8.15%335.22M | 6.99%364.97M | -21.54%341.13M | -1.90%434.8M | 18.51%443.21M |
-Reversal of impairment losses recognized in profit and loss | -26.26%59.34M | 49.40%80.47M | -70.60%53.86M | -46.58%183.18M | 163.41%342.9M | 20.56%130.18M | -40.58%107.98M | 38.94%181.73M | 161.15%130.79M | -64.84%50.08M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -131.12%-12.16M | 26.78%-5.26M |
-Disposal profit | 84.98%-19.16M | -406.49%-127.52M | -62.13%41.61M | 278.64%109.88M | -12.04%29.02M | 135.56%32.99M | -220.46%-92.78M | 3,180.37%77.02M | -77.22%2.35M | -85.09%10.31M |
-Other non-cash items | 152.79%13.78M | -232.25%-26.1M | 123.22%19.73M | -179.07%-84.97M | 2,913.60%107.47M | -95.68%3.57M | 23.43%82.53M | 395.57%66.86M | -178.84%-22.62M | -23.00%28.69M |
Changes in working capital | 61.22%-26.06M | -434.38%-67.2M | 76.87%-12.58M | -177.66%-54.36M | 238.82%70M | 129.06%20.66M | -1,115.02%-71.09M | 7.97%-5.85M | 32.90%-6.36M | 81.61%-9.48M |
-Change in receivables | 86.91%-27.53M | -89,416.17%-210.36M | -571.43%-235K | -100.04%-35K | 375.29%86.27M | -26.83%-31.34M | 48.06%-24.71M | -556.50%-47.57M | 83.26%-7.25M | -372.71%-43.28M |
-Change in inventory | -53.84%13.93M | 241.19%30.17M | -148.13%-21.37M | 1,212.66%44.39M | -94.31%3.38M | -3.02%59.41M | 464.54%61.26M | 114.25%10.85M | -373.71%-76.17M | 73.00%-16.08M |
-Change in payables | -99.62%414K | 1,246.86%107.75M | 110.87%8M | -216.76%-73.62M | -629.93%-23.24M | 97.08%-3.18M | -490.39%-108.98M | -63.78%27.92M | 177.23%77.06M | -279.29%-99.78M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 516.29%79.98M |
-Provision for loans, leases and other losses | -345.31%-12.87M | 411.00%5.25M | 104.09%1.03M | -799.05%-25.1M | 184.83%3.59M | -417.00%-4.23M | -54.79%1.34M | --2.95M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 257.38%69.68M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -62.59%-36.19M | 18.72%-22.26M | -30.21%-27.39M | -50.28%-21.03M | -0.47%-14M | 15.45%-13.93M | -9.02%-16.48M | -3.53%-15.11M | 22.50%-14.6M | 24.31%-18.84M |
Interest received (cash flow from operating activities) | 71.79%67K | -36.07%39K | -91.11%61K | 679.55%686K | -12.00%88K | -88.43%100K | 417.37%864K | -2.91%167K | -3.91%172K | -33.46%179K |
Tax refund paid | -168.00%-22.82M | 21.45%-8.52M | 50.61%-10.84M | 78.49%-21.95M | -160.78%-102.07M | -437.93%-39.14M | 111.14%11.58M | 18.30%-103.93M | -62.45%-127.2M | 33.00%-78.3M |
Other operating cash inflow (outflow) | 2,847.94%82.84M | -96.62%2.81M | 94.44%83.03M | 121.04%42.7M | -20,295,500.00%-202.96M | -200.00%-1K | 1K | 0 | -1K | 0 |
Operating cash flow | 266.69%328.44M | 40.09%-197.04M | 37.45%-328.91M | -387.50%-525.87M | -121.02%-107.87M | 10.84%513.17M | 20.86%462.96M | -18.85%383.06M | -26.35%472.06M | 16.51%640.97M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -276.87%-168.49M | -49.50%95.26M | 853.84%188.66M | 93.84%-25.03M | -26.39%-406.54M | -48.55%-321.67M | 46.49%-216.53M | -13.37%-404.63M | 0.62%-356.9M | 45.21%-359.14M |
Net intangibles purchase and sale | -4,283.77%-26.74M | 89.08%-610K | 75.34%-5.59M | -49.80%-22.66M | 38.19%-15.13M | 32.78%-24.47M | 1.27%-36.41M | -15.75%-36.87M | 39.36%-31.86M | 65.89%-52.53M |
Net business purchase and sale | --310.75M | --0 | ---- | ---- | ---- | ---- | ---- | --52.4M | ---- | ---- |
Net investment product transactions | ---- | ---- | --24M | ---- | ---- | ---- | 544.03%43.87M | ---9.88M | ---- | ---9.99M |
Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 75.00%-100K |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -39.17%528K |
Net changes in other investments | 148.22%12.74M | -2,950.16%-26.42M | -98.47%927K | 204.17%60.73M | 300.62%19.97M | -93.10%4.98M | 287.47%72.22M | -124.64%-38.52M | 1,853.91%156.33M | 115.89%8M |
Investing cash flow | 87.97%128.26M | -67.20%68.23M | 1,493.95%208M | 103.25%13.05M | -17.75%-401.7M | -149.29%-341.16M | 68.72%-136.85M | -88.23%-437.5M | 43.75%-232.43M | 51.91%-413.23M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 73.42%-18.58M | 65.04%-69.9M | -5,650.81%-199.94M | -99.49%3.6M | 418.27%701.96M | -47.77%-220.55M | -30.13%-149.26M | -2,740.45%-114.7M | 101.92%4.34M | 16.38%-225.85M |
Net common stock issuance | ---- | ---- | 484.83%804.65M | --137.59M | ---- | -75.51%-86K | 99.93%-49K | ---69.53M | ---- | ---- |
Increase or decrease of lease financing | ---32.81M | --0 | ---- | ---- | -54.07%-587K | ---381K | ---- | ---- | ---- | ---- |
Cash dividends paid | ---- | ---- | ---- | 99.81%-35K | ---18.79M | ---- | ---- | ---- | ---- | ---- |
Net other fund-raising expenses | ---25.87M | ---- | ---1K | ---- | -100.00%-2K | ---1K | ---- | ---- | ---- | ---- |
Financing cash flow | -10.52%-77.26M | -111.56%-69.9M | 328.41%604.71M | -79.32%141.15M | 408.83%682.58M | -48.03%-221.02M | 18.96%-149.31M | -4,340.98%-184.23M | 101.92%4.34M | 16.38%-225.85M |
Net cash flow | ||||||||||
Beginning cash position | -20.48%771.69M | 99.42%970.39M | -43.30%486.6M | 25.25%858.27M | -6.67%685.26M | 31.72%734.27M | -29.98%557.46M | 44.19%796.14M | 0.34%552.16M | -51.29%550.28M |
Current changes in cash | 290.96%379.45M | -141.07%-198.7M | 230.17%483.79M | -314.83%-371.67M | 453.01%173.01M | -127.72%-49.01M | 174.08%176.81M | -197.83%-238.68M | 12,863.60%243.98M | 100.32%1.88M |
Cash adjustments other than cash changes | ---- | 200.00%1K | -200.00%-1K | --1K | ---- | ---- | ---- | ---- | -200.00%-1K | --1K |
End cash Position | 49.17%1.15B | -20.48%771.69M | 99.42%970.39M | -43.30%486.6M | 25.25%858.27M | -6.67%685.26M | 31.72%734.27M | -29.98%557.46M | 44.19%796.14M | 0.34%552.16M |
Free cash flow | 129.44%132.31M | -26.04%-449.35M | 38.04%-356.53M | -0.76%-575.42M | -508.17%-571.09M | 42.65%139.91M | 125.88%98.08M | -560.98%-378.96M | -63.90%82.21M | 185.58%227.74M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |